Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Ewing 1

Interventions

Magnetic Resonance Spectroscopy 13pembrolizumab 8Nivolumab 8Biopsy 8Radiotherapy 7Specimen Handling 5Cyclophosphamide 5Temozolomide 4Radiosurgery 4fludarabine 3X-Rays 3Surgical Procedures, Operative 3Rituximab 3Paclitaxel 3Leukapheresis 3Ipilimumab 3Fluorodeoxyglucose F18 3Dexamethasone 3Bevacizumab 3Aspirin 3perflutren 2alovudine 2Vaccines 2Tirzepatide 2Positron-Emission Tomography 2Phantoms, Imaging 2Omeprazole 2Niacinamide 2Neoadjuvant Therapy 2Metastasectomy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × romiplostim × 90 days × Clear all
NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting
26 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡